PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
28-Aug-2025 BRAIN Biotech reports dynamic Q3 revenue growth in core segment BRAINBiocatalysts BRAIN Biotech AG
28-Aug-2025 Heidelberg Pharma’s Partner Telix Pharmaceuticals Gives Regulatory Update for its Imaging Agent TLX250-CDx Heidelberg Pharma AG
27-Aug-2025 CHEPLAPHARM with stable business in the first half of 2025 Cheplapharm AG
27-Aug-2025 STRATEC ENLARGES ITS BOARD OF MANAGEMENT  STRATEC SE
27-Aug-2025 BioVersys receives EMA Orphan Designation for the combination of alpibectir and ethionamide for the treatment of tuberculosis BioVersys AG
27-Aug-2025 FamiCord AG significantly increases revenue and earnings in the first half of 2025 and shifts focus even more strongly to core business in the future FamiCord AG
26-Aug-2025 Cambrex Expands Peptide Manufacturing Capabilities in Waltham, Massachusetts Cambrex
26-Aug-2025 Dermapharm confirms stable business development in H1 2025 and records EBITDA growth in Q2 versus prior-year quarter Dermapharm Holding SE
25-Aug-2025 Corbion and BRAIN Biotech team to shape the future of innovation in nature-based ingredient technologies BRAIN Biotech AG
21-Aug-2025 MeVis Medical Solutions AG: Forecast adjustment for the 2024/2025 fiscal year MeVis Medical Solutions AG
20-Aug-2025 APONTIS PHARMA: Changes in the management board APONTIS PHARMA AG
20-Aug-2025 New whitepaper details regulatory requirements needed for transition to low-GWP medical propellants Orbia Fluor & Energy Materials
19-Aug-2025 SKAN Group reports strong order intake in H1 2025 – full-year guidance confirmed SKAN AG
19-Aug-2025 DocMorris increases Rx revenue by over 40 per cent in the first half of the year and continues to expand its health ecosystem DocMorris AG
19-Aug-2025 Medartis delivers 15.3% organic sales growth in H1 and lifts sales guidance for the full-year Medartis Holding AG
19-Aug-2025 STRATEC REPORTS RESULTS FOR FIRST HALF OF 2025 STRATEC SE
18-Aug-2025 Nyxoah Reports Second Quarter Financial and Operating Results Nyxoah SA.
18-Aug-2025 Faron to advance bexmarilimab into a registrational Phase 2/3 study in treatment-naïve (frontline) HR-MDS after positive meeting with the FDA Faron Pharmaceuticals
15-Aug-2025 CureVac Announces Financial Results for the Second Quarter and First Half of 2025 and Provides Business Updates CureVac
14-Aug-2025 Top Pharma Manufacturing Job Vacancies PharmiWeb